Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Perloff

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Social Science & Medicine|February 1, 1974
Are neurotic patients in psychotropic drug trials representative? A comparison of study and non-study patients in four family practicesP Hesbacher, K Rickels, E L Clark, et al.
Cancer|April 1, 1979
High dose methotrexate followed by citrovorum factor reversal in patients with advanced cancerE P Ambinder, M Perloff, T Ohnuma, et al.
Diseases of the Nervous System|January 1, 1970
Drug treatment in depressive illnessK Rickels, P E Gordon, B W Jenkins, et al.
Cancer Chemotherapy Reports|November 1, 1974
Adriamycin (NSC-123127) in combination with cyclophosphamide (NSC-26271): a phase I and II evaluationF M Muggia, M Perloff, G A Chia, et al.
The American Journal of Clinical Nutrition|September 1, 1996
Plasma alpha-tocopherol concentrations after supplementation with water- and fat-soluble vitamin EN V Dimitrov, C Meyer-Leece, J McMillan, et al.
Clinics in Shoulder and Elbow|June 14, 2023
Variation in radial head fracture treatment recommendations in terrible triad injuries is not influenced by viewing two-dimensional computed tomographyEric M Perloff, Tom J Crijns, Casey M O'Connor, et al.
Journal of Immunological Methods|January 1, 1980
Radioisotopic 51Cr-leukocyte adherence inhibition (LAI) assay. I. Demonstration of anti-tumor immunity in patients with breast carcinomaP H Tsang, K Tangnavarad, G Lesnick, et al.
Journal of Clinical Pharmacology|February 1, 1974
Pipradrol in mild depression: a controlled studyK Rickels, B Schneider, J A Pereira-Ogan, et al.
Investigational New Drugs|November 1, 1992
Clinical pharmacology studies of oltipraz--a potential chemopreventive agentN V Dimitrov, J L Bennett, J McMillan, et al.
Cancer Treatment Reports|October 1, 1982
Aziridinylbenzoquinone (AZQ) in advanced breast cancer: a Cancer and Leukemia group B phase II trialD R Budman, A Forastiere, M Perloff, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Social Science & Medicine|February 1, 1974
Are neurotic patients in psychotropic drug trials representative? A comparison of study and non-study patients in four family practicesP Hesbacher, K Rickels, E L Clark, et al.
Cancer|April 1, 1979
High dose methotrexate followed by citrovorum factor reversal in patients with advanced cancerE P Ambinder, M Perloff, T Ohnuma, et al.
Diseases of the Nervous System|January 1, 1970
Drug treatment in depressive illnessK Rickels, P E Gordon, B W Jenkins, et al.
Cancer Chemotherapy Reports|November 1, 1974
Adriamycin (NSC-123127) in combination with cyclophosphamide (NSC-26271): a phase I and II evaluationF M Muggia, M Perloff, G A Chia, et al.
The American Journal of Clinical Nutrition|September 1, 1996
Plasma alpha-tocopherol concentrations after supplementation with water- and fat-soluble vitamin EN V Dimitrov, C Meyer-Leece, J McMillan, et al.
Clinics in Shoulder and Elbow|June 14, 2023
Variation in radial head fracture treatment recommendations in terrible triad injuries is not influenced by viewing two-dimensional computed tomographyEric M Perloff, Tom J Crijns, Casey M O'Connor, et al.
Journal of Immunological Methods|January 1, 1980
Radioisotopic 51Cr-leukocyte adherence inhibition (LAI) assay. I. Demonstration of anti-tumor immunity in patients with breast carcinomaP H Tsang, K Tangnavarad, G Lesnick, et al.
Journal of Clinical Pharmacology|February 1, 1974
Pipradrol in mild depression: a controlled studyK Rickels, B Schneider, J A Pereira-Ogan, et al.
Investigational New Drugs|November 1, 1992
Clinical pharmacology studies of oltipraz--a potential chemopreventive agentN V Dimitrov, J L Bennett, J McMillan, et al.
Cancer Treatment Reports|October 1, 1982
Aziridinylbenzoquinone (AZQ) in advanced breast cancer: a Cancer and Leukemia group B phase II trialD R Budman, A Forastiere, M Perloff, et al.
Pageof 7